Company Filing History:
Years Active: 2018-2024
Title: The Innovative Mind of Sai Man Liu
Introduction
Sai Man Liu, an accomplished inventor based in Abingdon, GB, has made significant contributions to the field of biotechnology. With a remarkable portfolio of seven patents, his work primarily focuses on the engineering of clostridial toxins, leading to advancements in medical applications.
Latest Patents
One of his latest inventions is centered around cationic neurotoxins. This invention presents engineered clostridial toxins that have at least one amino acid modification. This modification increases the isoelectric point (pi) of the engineered clostridial toxin to be at least 0.2 pi units higher than an otherwise identical clostridial toxin that lacks this modification. Notably, the amino acid modification is not located in the toxin binding domain (H-domain). This innovative approach not only enhances the properties of the toxins but also opens up new medical uses for these engineered compounds. Additionally, another significant patent involves a composition comprising recombinant clostridium neurotoxin, detailing methods for producing soluble di-chain BoNT/A protein.
Career Highlights
Sai Man Liu’s career is marked by his tenure at Ipsen Bioinnovation Limited, where he has been instrumental in pioneering research in neurotoxins. His innovative work has placed him at the forefront of his field, driving advancements that have practical implications in medicine.
Collaborations
Throughout his career, Liu has collaborated with notable professionals, including Gavin Stephen Hackett and Dina Brady Anderson. Such collaborations highlight his ability to work within a team of experts, further enhancing his innovative contributions to biotechnology.
Conclusion
In summary, Sai Man Liu exemplifies the essence of innovation in the biotechnology sector. His dedication to developing novel engineered clostridial toxins showcases not only his skill as an inventor but also his commitment to improving medical outcomes through scientific advancement. With additional patents likely on the horizon, Liu's contributions will undoubtedly continue to shape the future of biomedical innovation.